| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 19 | 19 | 21 | 14 | 16 | 8 | 12 | 10 | 8 | 6 | 6 | 7 |
| Expenses | 17 | 18 | 21 | 16 | 17 | 10 | 14 | 10 | 7 | 6 | 6 | 7 |
| EBITDA | 2 | 1 | 0 | -2 | -1 | -2 | -2 | 0 | 1 | -0 | -0 | -0 |
| Operating Profit % | 9 % | 4 % | -0 % | -14 % | -4 % | -27 % | -14 % | -1 % | 11 % | -3 % | -5 % | -4 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 0 | 0 | 1 |
| Profit Before Tax | 0 | -0 | -1 | -3 | -2 | -4 | -4 | -2 | -1 | -1 | -1 | -1 |
| Tax | 1 | -0 | -0 | -1 | -0 | -1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | -1 | 0 | -1 | -3 | -2 | -3 | -5 | -3 | -2 | -1 | -1 | -1 |
| EPS in ₹ | -1.04 | 0.04 | -0.77 | -2.51 | -1.68 | -2.84 | -4.96 | -3.26 | -1.75 | -1.19 | -1.24 | -1.20 |
Norris Medicines
Norris Medicines
16.79
+1.13
(7.22%)
Key Fundamentals
Market Cap
15.70 Cr
EPS
-1.24
PE Ratio
-14.23
Dividend Yield
0.00 %
Industry
Commercial Services 52 Week High
27.74
52 Week Low
14.78
PB Ratio
-1.14
Debt to Equity
0.00
Sector
Trading & Distributors Actual
Company News
View All News
Norris Medicines Limited Approves Unaudited Financial Results for Quarter Ended June 30, 2025Aug 14, 2025
Norris Medicines Limited's Board of Directors approved the unaudited financial results for the quarter ended June 30, 2025, along with the Limited Review Report at their meeting held on August 14, 2025. The board meeting commenced at 7:00 PM and concluded at 7:30 PM. The company will publish these unaudited financial results in newspapers as per regulatory requirements. The results and Limited Review Report have been submitted to BSE Limited.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
156.25 | #1 26,287.30 | 355.11 | 551.40 | 55,040.00 | 70 | 72.10 | 37.62 | |
268.90 | 21,240.80 | 11.46 | #1 99,561.70 | 11.11 | #1 1,821 | 7.37 | 48.14 | |
68.13 | 10,215.00 | 104.74 | 262.80 | 28.63 | 87 | 35.47 | 51.67 | |
536.20 | 3,822.70 | #1 8.88 | 387.50 | -25.38 | 407 | 7.63 | 55.95 | |
395.10 | 3,813.10 | 88.39 | 299.41 | #1 8,85,900.00 | 20 | #1 1,157.89 | 60.79 | |
142.14 | 2,608.70 | 65.78 | 262.20 | 79.10 | 23 | 307.14 | 36.07 | |
585.25 | 2,188.00 | 45.68 | 89.60 | 14.72 | 42 | 74.07 | 50.62 | |
144.32 | 1,883.00 | 37.78 | 312.50 | 136.92 | 40 | 208.70 | 47.95 | |
39.94 | 1,340.30 | 497.75 | 81.30 | 15.16 | 3 | 0.00 | 32.23 | |
34,300.00 | 1,054.30 | 9.65 | 67.60 | -16.34 | 115 | -19.54 | 6.24 |
Growth Rate
Revenue Growth
3.51 %
Net Income Growth
-
Cash Flow Change
200.00 %
ROE
-4.48 %
ROCE
37.56 %
EBITDA Margin (Avg.)
24.28 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 18 | 18 | 22 | 21 | 20 | 21 | 20 | 14 | 14 | 14 | 14 |
| Fixed Assets | 9 | 8 | 10 | 9 | 9 | 8 | 8 | 7 | 7 | 6 | 5 |
| Current Assets | 7 | 7 | 9 | 8 | 7 | 7 | 8 | 4 | 5 | 6 | 6 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 10 | 10 | 12 | 11 | 12 | 12 | 12 | 7 | 7 | 8 | 9 |
| Total Liabilities | 18 | 18 | 22 | 21 | 20 | 21 | 20 | 14 | 14 | 14 | 14 |
| Current Liabilities | 5 | 5 | 10 | 11 | 9 | 8 | 12 | 7 | 8 | 9 | 10 |
| Non Current Liabilities | 8 | 8 | 8 | 8 | 11 | 15 | 16 | 18 | 18 | 19 | 19 |
| Total Equity | 5 | 5 | 5 | 2 | 0 | -3 | -7 | -11 | -12 | -14 | -15 |
| Reserve & Surplus | -5 | -5 | -5 | -8 | -10 | -12 | -17 | -21 | -22 | -24 | -25 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -2 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | -1 | -0 | -2 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 |
| Operating Activities | -1 | 1 | -1 | 1 | -2 | -3 | 1 | -1 | 1 | 0 | 1 |
| Financing Activities | 0 | -1 | 3 | -1 | 2 | 3 | -1 | 1 | -1 | -0 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 34.04 % | 34.04 % | 34.04 % | 34.04 % | 34.04 % | 34.04 % | 34.04 % | 34.04 % | 34.04 % | 34.01 % | 34.01 % | 34.01 % | 34.01 % | 34.01 % | 34.01 % | 34.00 % | 34.00 % | 34.00 % | 34.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 20.60 % | 20.57 % | 20.56 % | 20.52 % | 20.60 % | 20.59 % | 20.60 % | 20.59 % | 20.56 % | 20.63 % | 20.66 % | 20.67 % | 20.70 % | 20.71 % | 20.72 % | 20.73 % | 20.76 % | 20.78 % | 20.79 % |
| Others | 45.29 % | 45.31 % | 45.32 % | 45.36 % | 45.29 % | 45.30 % | 45.28 % | 45.30 % | 45.33 % | 45.29 % | 45.25 % | 45.25 % | 45.22 % | 45.21 % | 45.20 % | 45.21 % | 45.17 % | 45.15 % | 45.14 % |
| No of Share Holders | 0 | 25,010 | 25,032 | 25,019 | 25,141 | 25,290 | 25,294 | 25,329 | 25,326 | 25,256 | 25,242 | 25,317 | 25,517 | 25,400 | 25,498 | 25,659 | 25,815 | 25,950 | 25,895 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Dec 2023 |  Annual General Meeting | NA | 14 Dec 2023 | 11.19 | 12.23 |
| 30 Jan 2024 |  Extraordinary General Meeting | NA | 30 Jan 2024 | 13.36 | 22.21 |
| 30 Sept 2024 | Annual General Meeting | NA | 30 Sept 2024 | 17.59 | 17.76 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 22.84 | 26.42 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 22.20 | 21.56 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 19.17 | 20.37 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 17.62 | 18.00 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 16.01 | 16.60 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
5 days ago
5 days agoVoting Results For 34Th AGM.Sep 29, 2025
Sep 29, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Sep 29, 2025Proceedings Of The 34Th Annual General Meeting Of Norris Medicines Limited Held For The Financial Year 2024-2025 On September 29Th 2025.Sep 29, 2025
Sep 29, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 12, 2025
Sep 12, 2025Intimation Of Cutoff Date For Remote E-Voting And Closure Of Register Of Members & Share Transfer Books At 34Th Annual General Meeting.Sep 05, 2025
Sep 05, 2025Letter To Shareholders In Terms Of Regulation 36(1)(B) Of The SEBI Listing Regulations.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Notice Of 34Th Annual General Meeting Of The Company.Sep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 01, 2025
Sep 01, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 01St September 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Sep 01, 2025
Sep 01, 2025Outcome Of Board Meeting Held On Thursday 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30Th 2025 And Other Matters.Aug 11, 2025
Aug 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2025
Jul 18, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Outcome Of The Board Meeting Held On May 28 2025_Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.May 28, 2025
May 28, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On May 28 2025_Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.May 28, 2025
May 28, 2025Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements 2015) For Holding Board Meeting For Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2025 And Other Matters.May 23, 2025
May 23, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Apr 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Apr 04, 2025Closure of Trading WindowMar 29, 2025
Mar 29, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Outcome Of Board Meeting Held On 13Th February 2025 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Feb 13, 2025
Feb 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated (Board Meeting Date) Pursuant To Regulation 30 And 31A (8) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Feb 13, 2025
Feb 13, 2025Board Meeting Intimation for Notice Of The Board Meeting Of 2024-25 Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Feb 10, 2025
Feb 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Jan 14, 2025Closure of Trading WindowDec 31, 2024
Dec 31, 2024Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 For Receipt Of Request Letter From Promoter Of The Company For Reclassification From Promoter & Promoter Group To Public Category.Dec 23, 2024
Dec 23, 2024Announcement under Regulation 30 (LODR)-Change in ManagementDec 06, 2024
Dec 06, 2024Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For Half Year Ended 30.09.2024.Nov 14, 2024
Nov 14, 2024Adoption Of Financials In Board Meeting Held On Thursday, 14Th November, 2024 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Nov 14, 2024
Nov 14, 2024Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, 14Th November, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Nov 14, 2024
Nov 14, 2024Board Meeting Intimation for Notice Of The Board Meeting Of 2024-25 Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Nov 11, 2024
Nov 11, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Oct 14, 2024Result Of Voting And Scrutinizers Report - 33Rd AGM Held On 30Th September 2024.Oct 01, 2024
Oct 01, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 01, 2024
Oct 01, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2024
Sep 30, 2024Intimation Of Change In Board Of Directors Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Sep 30, 2024
Sep 30, 2024Closure of Trading WindowSep 27, 2024
Sep 27, 2024Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 25, 2024
Sep 25, 2024Announcement under Regulation 30 (LODR)-Change in ManagementSep 25, 2024
Sep 25, 2024Board Meeting Outcome for Outcome Of The Board Meeting Held On 25Th September, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.Sep 25, 2024
Sep 25, 2024The Cut-Off Date For Determining The Eligibility Of Members To Avail The Facility Of Remote E-Voting Will Be Monday, 23Rd September, 2024.Sep 15, 2024
Sep 15, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2024
Sep 10, 2024Notice Of 33Rd AGM For The Financial Year 2023-24Sep 06, 2024
Sep 06, 2024Reg. 34 (1) Annual Report.Sep 06, 2024
Sep 06, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateAug 24, 2024
Aug 24, 2024Technical Indicators
RSI(14)
Neutral 54.98
ATR(14)
Volatile 1.16
STOCH(9,6)
Neutral 34.37
STOCH RSI(14)
Neutral 61.87
MACD(12,26)
Bullish 0.05
ADX(14)
Weak Trend 11.31
UO(9)
Bullish 24.98
ROC(12)
Uptrend And Accelerating 4.55
WillR(14)
Neutral -30.50
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
